FDA inspection
Jiangsu Xidi Pharmaceuticals Co., Ltd: FDA inspection ending Dec 10, 2020
FDA inspection 1134213 · No Action Indicated (NAI) · Nantong
Key facts
| Inspection ID | 1134213 |
|---|---|
| Firm | Jiangsu Xidi Pharmaceuticals Co., Ltd |
| FEI number | 3013431774 |
| Address | Life And, No 3 Jiang Feng Road; Jingjikaifa Qidong |
| City | Nantong |
| Fiscal year | 2021 |
| Inspection end date | Dec 10, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data